3rnn
From Proteopedia
(Difference between revisions)
m (Protected "3rnn" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | [[Image:3rnn.jpg|left|200px]] | |
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3rnn", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3rnn| PDB=3rnn | SCENE= }} | ||
| - | + | ===Crystal Structure of iGluR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator=== | |
| - | + | ||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21543522}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21543522 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21543522}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | [[3rnn]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3RNN OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021543522</ref><references group="xtra"/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Timm, D E.]] | ||
Revision as of 05:27, 25 May 2011
Crystal Structure of iGluR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Template:ABSTRACT PUBMED 21543522
About this Structure
3rnn is a 3 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Timm DM, Benveniste M, Weeks AM, Nisenbaum ES, Partin KM. Structural and Functional Analysis of Two New Positive Allosteric Modulators of GluA2 Desensitization and Deactivation. Mol Pharmacol. 2011 May 4. PMID:21543522 doi:10.1124/mol.110.070243
